Director & Co-Founder
Tier 1DrStore, India
Former Director Supply Chain and Institution Business at Abbott
Contact: +91 NA
India’s generic drug debate centers on lowering healthcare costs and improving access. However, inconsistent quality standards, weak regulation, and unqualified …
September 30, 2021
Pharma selling in India is evolving as doctors become self-informed. Traditional MR-led approaches are losing impact, pushing companies toward often …
July 15, 2021